Related Experiment Video
Updated: Aug 14, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Hyperglycemia increased brain ischemia injury through extracellular signal-regulated protein Kinase
Jian-Zhong Zhang1, Li Jing, Ai-Ling Ma
1Institute of Immunopathology, School of Life Science & Technology, Xi'an Jiaotong University, Xi'an 710061, China. zhangjz@nxmc.edu.cn
Abstract:
This study was to examine the alterations in the phosphorylation of mitogen-activated protein kinase (MAPK) family in transient brain ischemia under a hyperglycemia and to highlight the molecular mechanisms by which hyperglycemia exacerbates brain damage resulting from stroke. Extracellular signal-regulated protein kinase (ERK) expression was studied in rats subjected to global brain ischemia with pre-ischemic normoglycemic (CIN) and hyperglycemic (CIH) conditions. In another group, the hyperglycemic ischemic rats were pretreated with ERK inhibitor U0126 (U0126). Increased phospho-ERK1/2 immunoreactive neurons in the cingulate cortex and hippocampal CA3 were detected in CIN after ischemia and reperfusion. The numbers of phospho-ERK1/2-positive neurons were further increased significantly in CIH compared to the CIN. Pretreatment with U0126 in CIH rats significantly decreased ERK1/2 immunoreactive cells. Western blot analyses confirmed that phospho-ERK1/2 increased significantly after 30 min ischemia and reperfusion compared to non-ischemic controls in both the CIN and CIH groups. The increase of phospho-ERK1/2 was more prominent in the CIH than in the CIN group after 3 and 6h of reperfusion. Treatment with U0126 significantly reduced phospho-ERK1/2 in the CIH group. The findings presented here suggest that ERK1/2 may play a role in mediating neuronal cells death under hyperglycemic condition.
Insights
Hyperglycemia worsens brain damage after stroke by increasing extracellular signal-regulated kinase (ERK) phosphorylation. Inhibiting ERK reduces this damage, suggesting ERK
Area of Science:
- Neuroscience
- Molecular Biology
- Pathophysiology
Background:
- Transient brain ischemia, a common stroke complication, can be exacerbated by hyperglycemia.
- Mitogen-activated protein kinases (MAPKs), including Extracellular signal-regulated kinase (ERK), are implicated in cellular stress responses.
Purpose of the Study:
- To investigate the role of ERK phosphorylation in transient brain ischemia under hyperglycemic conditions.
- To elucidate the molecular mechanisms by which hyperglycemia worsens stroke-related brain damage.
Main Methods:
- Global brain ischemia was induced in rats under normoglycemic (CIN) and hyperglycemic (CIH) conditions.
- ERK phosphorylation was assessed using immunohistochemistry and Western blot analysis.
- The effect of an ERK inhibitor (U0126) on neuronal survival was evaluated in hyperglycemic ischemic rats.
Main Results:
- Increased phospho-ERK1/2 immunoreactive neurons were observed in the cingulate cortex and hippocampus after ischemia/reperfusion in both CIN and CIH groups.
- Hyperglycemia (CIH) led to a significant increase in phospho-ERK1/2-positive neurons compared to normoglycemic conditions (CIN).
- U0126 treatment significantly reduced phospho-ERK1/2 levels and immunoreactive cells in CIH rats, indicating ERK pathway involvement.
Conclusions:
- ERK1/2 phosphorylation is upregulated during transient brain ischemia and significantly enhanced under hyperglycemic conditions.
- Hyperglycemia exacerbates ischemic brain injury, at least partly, through increased ERK1/2 activation.
- Targeting the ERK pathway may offer a therapeutic strategy to mitigate brain damage in stroke patients with hyperglycemia.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Hyperglycemia
Hypoglycemia and Glucagon
Insulin: The Receptor and Signaling Pathways
Cytotoxic Edema: Pathophysiology
Acute Pancreatitis II: Pathophysiology
